Literature DB >> 456238

Active E rosette-forming cells in the peripheral blood of patients with chronic active hepatitis.

M C de Moura, F Ramalho.   

Abstract

E rosette-forming cells (E-RFC) and active E-RFC were studied in the peripheral blood in patients with chronic active hepatitis (CAH), chronic persistent hepatitis (CPH), and in control subjects. A significant reduction in active E-RFC (a subpopulation of T lymphocytes considered actively involved in cell-mediated immune reactions) was found in patients with untreated CAH, both HBSAg positive or negative. In contrast, patients with immunosuppressive-treated CAH showed an increased relative number of active E-RFC. A significant increase in active E-RFC was demonstrable in other immunosuppressive-treated chronic inflammatory disorders. In CPH active E-RFC were not different from normal controls. The number of E-RFC showed a relative and absolute decrease in both CPH and untreated CAH. These studies demonstrate an increase in active E-RFC in immunosuppressive-treated CAH and suggest that prednisone and azathioprine may have a differential effect on T lymphocyte subpopulations.

Entities:  

Mesh:

Year:  1979        PMID: 456238     DOI: 10.1007/bf01489318

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  The active E rosette test: correlation with delayed cutaneous hypersensitivity.

Authors:  P J Felsburg; R Edelman; R H Bilman
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

2.  Editorial: T-rosette forming cells, cellular immunity and cancer.

Authors:  H H Fudenberg; J Wybran; D Robbins
Journal:  N Engl J Med       Date:  1975-02-27       Impact factor: 91.245

3.  The formation of stable E-rosettes by human T lymphocytes activated in mixed lymphocyte reactions.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

4.  Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminish B lymphocyte responsiveness in in vitro immunoglobulin synthesis.

Authors:  A Saxon; R H Stevens; S J Ramer; P J Clements; D T Yu
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

5.  Differential effect of vinblastine and colchicine on human active and total T rosettes.

Authors:  J Wybran; A Govaerts; H Fudenberg
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

6.  Decreased suppressor cell activity in inflammatory bowel disease.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

7.  Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors.

Authors:  R R Coombs; B W Gurner; A B Wilson; G Holm; B Lindgren
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

8.  Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

Authors:  S W Schalm; W H Summerskill; G L Gitnick; L R Elveback
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

9.  Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.

Authors:  M C de Moura; S J Vernace; F Paronetto
Journal:  Gastroenterology       Date:  1975-08       Impact factor: 22.682

10.  Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes.

Authors:  R J Dehoratius; C Henderson; R G Strickland
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.